Successful Immunization of an Allogeneic Bone Marrow Transplant Recipient with Live, Attenuated Yellow Fever Vaccine
Version of Record online: 4 MAY 2009
© 2009 International Society of Travel Medicine
Journal of Travel Medicine
Volume 16, Issue 5, pages 365–367, September/October 2009
How to Cite
Yax, J. A., Farnon, E. C. and Cary Engleberg, N. (2009), Successful Immunization of an Allogeneic Bone Marrow Transplant Recipient with Live, Attenuated Yellow Fever Vaccine. Journal of Travel Medicine, 16: 365–367. doi: 10.1111/j.1708-8305.2009.00336.x
- Issue online: 24 SEP 2009
- Version of Record online: 4 MAY 2009
- 1Centers for Disease Control and Prevention. Health information for international travel 2008. Atlanta: US Department of Health and Human Services, Public Health Service, 2007.
- 2Centers for Disease Control and Prevention. Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients: recommendations of CDC, the Infectious Disease Society of America, and the American Society of Blood and Marrow Transplantation. MMWR Morb Mortal Wkly Rep 2000; 49(RR-10): 99.
- 3Committee to Advise on Tropical Medicine and Travel (CATMAT). The immunocompromised traveler. Can Commun Dis Rep 2007; 33(ACS-4): 1–24.
- 9Fatal myeloencephalitis following yellow fever vaccination in a case with HIV infection. J Med Assoc Thai 2002; 85: 131–134., ,
- 10Yellow fever vaccine. In: PlotkinS, OrenstienW, eds. Vaccines. 4th ed. Phila: WB Saunders, 2003; 1095–176.